Active Biotech AB (publ) (STO:ACTI)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.1172
-0.0076 (-6.09%)
May 19, 2025, 5:29 PM CET
-49.11%
Market Cap 144.18M
Revenue (ttm) n/a
Net Income (ttm) -39.90M
Shares Out 1.23B
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,647,923
Average Volume 20,906,394
Open 0.1248
Previous Close 0.1248
Day's Range 0.1148 - 0.1260
52-Week Range 0.0630 - 0.5170
Beta 0.72
RSI 70.24
Earnings Date May 8, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company has... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1983
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACTI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.